Altered Sialylation and Sialyltransferase Expression in Gynecologic Cancers

Taiwanese Journal of Obstetrics and Gynecology

Volumn 43, Issue 2, 2004, Pages 53-63

  Wang, Peng Hui ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

neoplasms of the cervix; prognosis; sialic acid; sialyltransferase

Indexed keywords

EID: 12344255408     PISSN: None     EISSN: 10284559     Source Type: Journal    
DOI: 10.1016/S1028-4559(09)60057-7     Document Type: Review

References (128)

1. Halliday A.J., Franks A.H., Ramsdale T.E., Martin R., and Palant E. A rapid semi-automated method for detection of Galβ1-4GlcNAc α2,6 sialyltransferase (EC2.4.99.1) activity using the lectin Sambucus nigra agglutinin. Glycobiology 11 (2001) 557-564
2. Apweiler R., Hermjakob H., and Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta 1473 (1999) 4-8
3. Marchal I., Golfier G., Dugas O., and Majed M. Bioinformatics in glycobiology. Biochimie 85 (2003) 75-81
4. 12 structures for a reducing hexaccharide: the isomer barrier to development of single-method saccharide sequencing or synthesis systems. Glycobiology 4 (1994) 759-767
5. Petretti T., Kemmner W., Schulze B., and Schlag P.M. Altered mRNA expression of glycosyltransferase in human colorectal carcinomas and liver metastases. Gut 46 (2000) 359-366
6. Lowe J.B. Carbohydrate recognition in cell-cell interaction. In: Fukuda M., and Hindsgaul O. (Eds). Molecular Glycobiology (1994), Oxford University Press, Oxford 163-194
7. Gabius H.J., Andre S., Kaltner H., and Siebert H.C. The sugar code: functional lectinomics. Biochim Biophys Acta 1572 (2002) 165-177
8. Thomas P. Cell surface sialic acid as a mediator of metastatic potential in colorectal cancer. Cancer J 9 (1996) 1-10
9. Schauer R. Sialic acids and their role as biological masks. Trends Biochem Sci 10 (1985) 357-360
10. Kim Y.J., Kim K.S., Kim S.H., et al. Molecular cloning and expression of human Galβ1,3GalNacα2,3-sialyltransferase (hST3Gal II). Biochim Biophys Res Commun 228 (1996) 324-327
11. Lee K.Y., Kim H.G., Hwang M.R., et al. The hexapeptide inhibitor of Galβ1,3GalNAc-specific α2,3-sialyltransferase as a generic inhibitor of sialyltransferases. J Biol Chem 277 (2002) 49341-49351
12. Fukuda M. Possible roles of tumor-associated carbohydrate antigens. Cancer Res 56 (1996) 2237-2244
13. Hakomori S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 56 (1996) 5309-5318
14. Dorudi S., Kinrade E., Marshall N.C., Feakins R., Williams N.S., and Bustin S.A. Genetic detection of lymph node micrometastases in patients with colorectal cancer. Br J Surg 85 (1998) 98-100
15. Aubert M., Panicot L., Crotte C., Gibier P., Lombardo D., Sadoulet M.O., and Mas E. Restoration of α(1,2) fucosyltransferase activity decreases adhesive and metastatic properties of human pancreatic cancer cells. Cancer Res 60 (2000) 1449-1456
16. Zhu Y., Srivatana U., Ullah A., Gagneja H., Berenson C.S., and Lance P. Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro. Biochim Biophys Acta 1536 (2001) 148-160
17. Yamamoto H., Oviedo A., Sweeley C., Saito T., and Moskal J.R. α2,6-sialylation of cell-surface N-glycans inhibits glioma formation in vivo. Cancer Res 61 (2001) 6822-6829
18. Schneider F., Kemmner W., Haensch W., Franke G., Gretschel S., Karsten U., and Schlag P.M. Overexpression of sialyltransferase CMP-sialic acid: Galβ1,3GalNAc-Rα6-sialyltransferase is related to poor patient survival in human colorectal carcinomas. Cancer Res 61 (2001) 4605-4611
19. Wang P.H., Li Y.F., Juang C.M., Lee Y.R., Chao H.T., Tsai Y.C., and Yuan C.C. Altered mRNA expression of sialyltransferase in squamous cell carcinomas of the cervix. Gynecol Oncol 83 (2001) 121-127
20. Wu C.Y., Hsu C.C., Chen S.T., and Tsai Y.C. Soyasaponin I, a potent and specific sialyltransferase inhibitor. Biochem Biophy Res Commun 284 (2001) 466-469
21. Recchi M.A., Hebbar M., Hornez L., Harduin-Lepers A., Peyrat J.P., and Delannoy P. Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res 58 (1998) 4066-4070
22. Recchi M.A., Harduin-Lepers A., Boilly-Marer Y., Verbert A., and Delannoy P. Multiplex RT-PCR method for the analysis of the expression of human sialyltransferase: application to breast cancer cells. Glycoconj J 15 (1998) 19-27
23. Brockhausen I., Yang J., Lehotay M., Ogata S., and Itzkowitz S. Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated sialyl-Tn antigen expression. Biol Chem 382 (2001) 219-232
24. Kannagi R. Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconj J 14 (1997) 577-584
25. Harduin-Lepers A., Recchi M.A., and Delannoy P. 1994, the years of sialyltransferase. Glycobiology 5 (1995) 741-758
26. Tsuji S. Molecular cloning and functional analysis of sialyl-transferases. J Biochem (Tokyo) 120 (1996) 1-13
27. Takashima S., Tachida Y., Nakagawa T., Hamamoto T., and Tsuji S. Quantitative analysis of expression of mouse sialyltransferase gene by competitive PCR. Biochem Biophys Res Commun 260 (1999) 23-27
28. Datta A.K., and Paulson J.C. The sialyltransferase 'sialylmotif' participates in binding the donor substrate CMP-NeuAc. J Biol Chem 270 (1995) 1497-1500
29. Martin L.T., Marth J.D., Varki A., and Varki N.M. Genetically altered mice with different sialyltransferases deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation. J Biol Chem 277 (2002) 32930-32938
30. Itzkowitz S.H., Yuan M., Montgomery C.K., Kjeldsen T., Takahashi H.K., Bigbee W.L., and Kim Y.S. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res 49 (1989) 197-204
31. Ura Y., Dion A.S., Williams C.J., et al. Quantitative dot blot analyses of blood-group-related antigens in paired normal and malignant human breast tissues. Int J Cancer 50 (1992) 57-63
32. Burchell J., Poulsom R., Hanby A., et al. A α2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas. Glycobiology 9 (1999) 1307-1311
33. x, the carbohydrate ligands for E-selectin, in human breast cancer. Int J Oncol 12 (1998) 1157-1164
34. Ito H., Hiraiwa N., Sawada-Kasugai M., et al. Altered mRNA expression of specific molecular species of fucosyl- and sialyl-transferases in human colorectal cancer tissues. Int J Cancer 71 (1997) 556-564
35. a expression and fucosyltransferase activity with acquisition of a high metastatic capacity in a colon cancer cell line. Br J Cancer 76 (1997) 582-587
36. Kudo T., Ikehara Y., Togayachi A., et al. Up-regulation of a set of glycosyltransferase genes in human colorectal cancer. Lab Invest 78 (1998) 797-811
37. Dall'Olio F.D., Chiricolo M., and Lau J.T. Differential expression of the hepatic transcript of β-galactoside α2,6 sialyltransferase in human colon cancer cell lines. Int J Cancer 81 (1999) 243-247
38. Bosch J., Brossmer R., Kemmner W., and Schlag P. Preparation and characterization of differently aggregated colorectal carcinoma cell subpopulations from surgical specimens. Cancer Detect Prev 22 (1998) 319-329
39. Ogawa J.I., Inoue H., and Koide S. α-2,3-sialyltransferase type 3N and α-1,3-focosyltransferase type VII are related to sialyl Lewis synthesis and patient survival from lung carcinoma. Cancer 79 (1997) 1678-1685
40. Ogawa J., Tsurumi T., Yamada S., Koide S., and Shohtsu A. Blood vessel invasion and expression of sialyl Lewis and proliferation cell nuclear antigen in stage I non-small cell lung cancer. Cancer 73 (1993) 1177-1183
41. Pousset D., Piller V., Bureaud N., Monsigny M., and Piller F. Increased α-2,6 sialylation of N-Glycans in a transgenic mouse model of hepatocellular carcinoma. Cancer Res 57 (1997) 4249-4256
42. Liu F., Qi H.L., and Chen H.L. Regulation of differentiation and proliferation-inducer on Lewis antigens, α-fucosyltransferase and metastatic potential in hepatocarcinoma cells. Br J Cancer 84 (2001) 1556-1563
43. Petretti T., Schulze B., Schlag P.M., and Kemmner W. Altered mRNA expression of glycosyltransferases in human gastric carcinomas. Biochim Biophys Acta 1428 (1999) 209-218
44. Bergler W., Riedel F., Schwartz-Albiez R., Gross H.J., and Hormann K. A new histobiochemical method to analyze sialylation on cell-surface glycoproteins of head and neck squamous-cell carcinomas. Eur Arch Otorhinolaryngol 254 (1997) 437-441
45. Yamamoto H., Saito T., Kaneko Y., et al. α2,3-sialyltransferase mRNA and α2,3-linked glycoprotein sialylation are increased in malignant gliomas. Brain Res 755 (1997) 175-179
46. Kaneko Y., Yamamoto H., Kersey D.S., Colley K.J., Leestma J.E., and Moskal J.R. The expression of Galβ1,4GlcNAc α2,6 sialyltransferase and α2,6-linked sialoglycoconjugates in human brain tumors. Acta Neuropathol (Berl) 91 (1996) 284-292
47. Fukushima K., Hara-Kuge S., Seko A., Ikehara Y., and Yamashita K. Elevation of α2 → 6 sialyltransferase and α1 → 2 fucosyltransferase activities in human choriocarcinoma. Cancer Res 58 (1998) 4301-4306
48. Okajima T., Fukumoto S., Miyazaki H., et al. Molecular cloning of a novel α2,3-sialyltransferase (ST3Gal IV) that sialylates type II lactosamine structures on glycoproteins and glycolipids. J Biol Chem 274 (1999) 11479-11486
49. Wang P.H., Li Y.F., Juang C.M., et al. Expression of sialyltransferase family members in cervical squamous cell carcinoma correlates with lymph node metastases. Gynecol Oncol 86 (2002) 45-52
50. Wang P.H., Lee W.L., Lee Y.R., et al. Enhanced expression of 2,6-sialyltransferase ST6Gal I in cervical squamous cell carcinoma. Gynecol Oncol 89 (2003) 395-401
51. Chen C.L., Lee W.L., Tsai Y.C., Yuan C.C., Ng H.T., and Wang P.H. Sialyltransferase family members and cervix squamous cell carcinoma. Eur J Gynaecol Oncol 23 (2002) 514-518
52. Taniguchi A., Hioki M., and Matsumoto K. Transcriptional regulation of human Galβ1,3GalNAc/Galβ1,4Glcα2,3-sialyltransferase (hST4Gal IV) gene in testis and ovary cell line. Biochem Biophys Res Commun 301 (2003) 764-768
53. Kitagawa H., and Paulson J.C. Differential expression of five sialyltransferase genes in human tissues. J Biol Chem 269 (1994) 17872-17878
54. Paulson J.C., Weistein J., and Schauer A. Tissue-specific expression of sialyltransferases. J Biol Chem 264 (1989) 10931-10934
55. Aasheim H.C., Aas-Eng D.A., Deggerdal A., Blomhoff H.K., Funderud S., and Smeland E.B. Cell-specific expression of human beta-galactoside alpha-2,6-sialyltransferase transcripts differing in the 5′-untranslated region. Eur J Biochem 213 (1993) 467-475
56. Lo N.W., and Lau J.T. Transcription of the beta-galactoside alpha2, 6-sialyltransferase gene (SIAT1) in B-lymphocytes: cell type-specific expression correlates with presence of the divergent 5′-untranslated sequence. Glycobiology 9 (1999) 907-914
57. Aas-Eng D.A., Asheim H.C., Deggerdal A., Smeland E., and Funderud S. Characterization of a promoter region supporting transcription of a novel human beta-galactoside alpha-2,6-sialyltransferase transcript in HepG2 cells. Biochim Biophys Acta 1261 (1995) 166-169
58. Stamenkovic I., Asheim H.C., Deggerdal A., Blomhoff H.K., Smeland E.B., and Funderud S. The B cell antigen CD75 is a cell surface sialyltransferase. J Exp Med 172 (1990) 641-643
59. Wang X., O'Hanlon T.P., Young R.F., and Lau J.T. Rat β-galactoside α2,6-sialyltransferase genomic organization: alternate promoters direct the synthesis of liver and kidney transcripts. Glycobiology 1 (1990) 25-31
60. Grundmann U., Nerlich C., Rein T., and Zettlmeissl G. Complete cDNA sequence encoding human beta-galactoside alpha-2, 6-sialyltransferase. Nucl Acids Res 18 (1990) 667-668
61. Wen D.X., Svensson E.C., and Paulson J.C. Tissue-specific alternative splicing of the β-galactoside α2,6-sialyltransferase gene. J Biol Chem 267 (1992) 2512-2518
62. Taniguchi A., Hasegawa Y., Higai K., and Matsumoto K. Tran-scriptional regulation of human beta-galactoside α2,6-sialyltransferase (hST6Gal I) gene during differentiation of the HL-60 cell line. Glycobiology 10 (2000) 623-628
63. Dall'Olio F. The sialyl-α2,6-lactosaminyl-structure: biosyn-thesis and functional role. Glycoconj J 17 (2000) 669-676
64. Wang X., Vertino A., Eddy R.L., Byers M.G., Jani-Sait S.N., Shows T.B., and Lau J.T. Chromosome mapping and organization of the human β-galactoside α2,6-sialyltransferase gene. Differential and cell-type specific usage of upstream exon sequences in B-lymphoblastoid cells. J Biol Chem 268 (1993) 4355-4361
65. Xu L., Kurusu Y., Takizawa K., Tanaka J., Matsumoto K., and Taniguchi A. Transcriptional regulation of human beta-galactoside alpha2,6-sialyltransferase (hST6Gal I) gene in colon adenocarcinoma cell line. Biochem Biophys Res Commun 307 (2003) 1070-1074
66. Dall'Olio F., Chiricolo M., Ceccarelli C., Minni F., Marrano D., and Santini D. Beta-galactoside alpha2,6 sialyltransferase in human colon cancer: contribution of multiple transcripts to regulation of enzyme activity and reactivity with Sambucus nigra agglutinin. Int J Cancer 88 (2000) 58-65
67. Kitagawa H., and Paulson J.C. Cloning of a novel alpha2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups. J Biol Chem 269 (1994) 1394-1401
68. Kitagawa H., Mattei M.G., and Paulson J.C. Genomic organization and chromosomal mapping of the Gal beta 1,3GalNAc/Gal beta 1,4GlcNAc alpha 2,3-sialyltransferase. J Biol Chem 271 (1996) 931-938
69. Taniguchi A., and Matsumoto K. Down-regulation of human sialyltransferase gene expression during in vitro human keratinocyte cell line differentiation. Biochem Biophys Res Commun 243 (1998) 177-183
70. Taniguchi A., and Matsumoto K. Epithelial-cell-specific transcriptional regulation of human Galbeta1,3GalNAc/Galbeta1,4GlcNAc alpha2,3-sialyltransferase (hST3Gal IV) gene. Biochem Biophys Res Commun 257 (1999) 516-522
71. Eckert R.L., Crish J.F., Banks E.B., and Welter J.F. The epidermis: genes on - genes off. J Invest Dermatol 109 (1997) 501-509
72. Leask A., Byrne C., and Fuchs E. Transcription factor AP2 and its role in epidermal-specific gene expression. Proc Natl Acad Sci USA 88 (1991) 7948-7952
73. Grahn A., Barkhordar G.S., and Larson G. Cloning and sequencing of nineteen transcript isoforms of the human alpha2,3-sialyltransferase gene, ST3Gal III; its genomic organization and expression in human tissues. Glycoconj J 19 (2002) 197-210
74. Taniguchi A., Saito K., Kubota T., and Matsumoto K. Characterization of the promoter region of the human Galbeta1,3(4)GlcNAc alpha2,3-sialyltransferase III (hST3Gal III) gene. Biochim Biophys Acta 1626 (2003) 92-96
75. Tapper J., Butzow R., Wahlstrom T., Seppala M., and Knuutila S. Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas. Br J Cancer 75 (1997) 1782-1787
76. Wang P.H., Yuan C.C., Juan C.M., Lai C.R., Yen M.S., Chao H.T., and Ng H.T. Primary epithelial ovarian carcinoma in Taiwanese women. Eur J Gynaecol Oncol 22 (2001) 57-60
77. Wang P.H., Chao K.C., Yen M.S., and Ng H.T. Accidentally delayed diagnosis of ruptured ovarian carcinoma in a young woman: a case report. Chin Med J (Taipei) 62 (1999) 728-732
78. Lin J.J., Yen C.C., Wang P.H., Chao K.C., Yen M.S., Yuan C.C., and Ng H.T. Ruptured metastatic ovarian carcinoma presenting as acute abdomen: a case report. Chin Med J (Taipei) 63 (2000) 247-250
79. Wang P.H., Yuan C.C., Shyong W.Y., Chiang S.C., Chao J.Y., Yen M.S., and Ng H.T. Optimal debulking surgery seems to be an independent prognostic factor in patients with FIGO IIIC primary epithelial ovarian carcinoma. Chin Med J (Taipei) 63 (2000) 220-225
80. Wang P.H., and Chang C. Androgens and ovarian cancers. Eur J Gynaecol Oncol 25 (2004) 157-163
81. nd edition (2001), Lippincott Williams & Wilkins, Philadelphia 57-96
82. Wang P.H., Shyong W.Y., Li Y.F., et al. BRCA1 mutations in Taiwanese with epithelial ovarian carcinoma, and sporadic primary serious peritoneal carcinoma. Jpn J Clin Oncol 30 (2000) 343-348
83. Brockhausen I. Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta 1473 (1999) 67-95
84. Loannides C., Fisk B., Jerome K., Irimura T., Wharton J., and Finn J. Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides. J Immunol 151 (1993) 3693-3703
85. Lloyd K.O., Yin B.W., and Kudryashov V. Isolation and characterization of ovarian cancer antigen CA125 using a new monoclonal antibody (VK-8): identification as a mucin-type molecule. Int J Cancer 71 (1997) 842-850
86. Inoue M., Ton S., Ogawa H., and Tanizawa O. Expression of Tn and sialyl-Tn antigens in tumor tissues of the ovary. Am J Clin Pathol 96 (1991) 711-716
87. Inoue M., Fujita M., Nakazawa A., Ogawa H., and Tanizawa O. Sialyl-Tn, sialyl-Lewis Xi, CA 19-9, CA 125, carcinoembryonic antigen, and tissue polypeptide antigen in differentiating ovarian cancer from benign tumors. Obstet Gynecol 79 (1992) 434-440
88. Inoue M., Ogawa H., Nakanishi K., Tanizawa O., Karino K., and Endo J. Clinical value of sialyl Tn antigen in patients with gynecologic tumors. Obstet Gynecol 75 (1990) 1032-1036
89. Kobayashi H., Terao T., and Kawashima Y. Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer. J Clin Oncol 10 (1992) 95-101
90. Chandrasekaran E.V., Jain R.K., and Matta K.L. Ovarian cancer alpha1, 3-L-fucosyltransferase. J Biol Chem 267 (1992) 23806-23814
91. Thompson S., Cantwell B.M., Matta K.L., and Turner G.A. Parallel changes in the blood levels of abnormally-fucosylated haptoglobin and alpha 1,3 fucosyltransferase in relationship to tumor burden: more evidence for a disturbance of fucose metabolism in cancer. Cancer Lett 65 (1992) 115-121
92. Kojima N., Handa K., Newman W., and Hakomori S. Multirecognition capability of E-selectin in a dynamic flow system, as evidenced by differential effects of sialidases and anticarbohydrate antibodies on selectin-mediated cell adhesion at low vs. high wall shear stress: a preliminary note. Biochem Biophys Res Commun 189 (1992) 1686-1694
93. Kojima N., Shiota M., Sadahira Y., Handa K., and Hakomori S. Cell adhesion in a dynamic flow system as compared to a static system. Glycosphingolipid-glycosphingolipid interaction in the dynamic system predominates over lectin- or integrin-based mechanisms in adhesion of B16 melanoma cells to non-activated endothelial cells. J Biol Chem 267 (1992) 17264-17270
94. Kojima N., Handa K., Newman W., and Hakomori S. Inhibition of selectin-dependent tumor cell adhesion to endothelial cells and platelets by blocking O-glycosylation of these cells. Biochem Biophys Res Commun 182 (1992) 1288-1295
95. Nakano T., Matsui T., and Ota T. Benzyl-alpha-GalNAc inhibits sialylation of O-glycosidic sugar chains on CD44 and enhances experimental metastatic capacity in B16BL6 melanoma cells. Anticancer Res 16 (1996) 3577-3584
96. Yoon W.H., Park H.D., Lim K., and Hwang B.D. Effect of O-glycosylated mucin on invasion and metastasis of HM7 human colon cancer cells. Biochem Biophys Res Commun 222 (1996) 694-699
97. Bresalier R.S., Niv Y., Byrd J.C., et al. Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J Clin Invest 87 (1991) 1037-1045
98. Huang J., Byrd J.C., Yoon W.H., and Kim Y.S. Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells. Oncol Res 4 (1992) 507-515
99. Byrd J.C., Dahiya R., Huang J., and Kim Y.S. Inhibition of mucin synthesis by benzyl-alpha-GalNAc in KATO III gastric cancer and Caco-2 colon cancer cells. Eur J Cancer 31A (1995) 1498-1505
100. Inoue M., Ogawa H., Nakanishi K., Tanizawa O., Karino K., and Endo J. Clinical value of sialyl Tn antigen in patients with gynecologic tumors. Obstet Gynecol 75 (1990) 1032-1036
101. Ogawa H., Inoue M., Tanizawa O., Miyamoto M., and Sakurai M. Altered expression of sialyl-Tn, Lewis antigens and carcinoembryonic antigen between primary and metastatic lesions of uterine cervical cancers. Histochemistry 97 (1992) 311-317
102. Matsushita Y., Nakamori S., Seftor E.A., Hendrix M.J., and Irimura T. Human colon carcinoma cells with increased invasive capacity obtained by selection for sialyl-dimeric LeX antigen. Exp Cell Res 196 (1991) 20-25
103. Hoff S.D., Matsushita Y., Ota D.M., Cleary K.R., Yamori T., Hakomori S., and Irimura T. Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma. Cancer Res 49 (1989) 6883-6888
104. Matsushita Y., Hoff S.D., Nudelman E.D., et al. Metastatic behavior and cell surface properties of HT-29 human colon carcinoma variant cells selected for their differential expression of sialyl-dimeric Le(x)-antigen. Clin Exp Metastasis 9 (1991) 283-299
105. Yogeeswaran G., and Salk P.L. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines. Science 212 (1981) 1514-1516
106. Kijima-Suda I., Miyamoto Y., Toyoshima S., Itoh M., and Osawa T. Inhibition of experimental pulmonary metastasis of mouse colon adenocarcinoma 26 sublines by a sialic acid:nucleoside conjugate having sialyltransferase inhibiting activity. Cancer Res 46 (1986) 858-862
107. Bresalier R.S., Ho S.B., Schoeppner H.L., Kim Y.S., Sleisenger M.H., Brodt P., and Byrd J.C. Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis. Gastroenterology 110 (1996) 1354-1367
108. Schwartz B., Bresalier R.S., and Kim Y.S. The role of mucin in colon-cancer metastasis. Int J Cancer 52 (1992) 60-65
109. Carraway K.L., Fregien N., Carraway III K.L., and Carraway C.A. Tumor sialomucin complexes as tumor antigens and modulators of cellular interactions and proliferation. J Cell Sci 103 (1992) 299-307
110. Dennis J.W., Waller C.A., and Schirrmacher V. Identification of asparagine-linked oligosaccharides involved in tumor cell adhesion to laminin and type IV collagen. J Cell Biol 99 (1984) 1416-1423
111. Dennis J.W., Laferte S., Yagel S., and Breitman M.L. Asparagine-linked oligosaccharides associated with metastatic cancer. Cancer Cells 1 (1989) 87-92
112. Dennis J.W., Laferte S., Waghorne C., Breitman M.L., and Kerbel R.S. Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 236 (1987) 582-585
113. Matsushita Y., Yonezawa S., Nakamori S., Irimura T., and Sato E. Carbohydrate antigens aberrantly expressed in colorectal carcinoma. Crit Rev Oncol Hematol 25 (1997) 27-54
114. Sharon N., and Lis H. Lectins: cell-agglutinating and sugar-specific proteins. Science 177 (1972) 949-959
115. Goldstein I.J., Hughes R.C., Monsigny M., Osawa T., and Sharon N. What should be called a lectin?. Nature 285 (1980) 66
116. Lis H., and Sharon N. Lectins: carbohydrate-specific proteins that mediate cellular recognition. Chem Rev 98 (1998) 637-674
117. Osawa T., and Tsuji T. Fractionation and structural assessment of oligosaccharides and glycopeptides by use of immobilized lectins. Ann Rev Biochem 56 (1987) 21-42
118. Yonezawa S., Nakamura T., Tanaka S., and Sato E. Glycoconjugate with Ulex europaeus agglutinin-I-binding sites in normal mucosa, adenoma, and carcinoma of the human large bowel. J Natl Cancer Inst 69 (1982) 777-785
119. Miyauchi T., Yonezawa S., Takamura T., et al. A new fucosyl antigen expressed on colon adenocarcinoma and embryonic carcinoma cells. Nature 299 (1982) 168-169
120. Matsushita Y., Yonezawa S., Nakamura T., Shimizu S., Ozawa M., Muramatsu T., and Sato E. Carcinoma-specific Ulex europaeus agglutinin-I binding glycoproteins of human colorectal carcinoma and its relation to carcinoembryonic antigen. J Natl Cancer Inst 75 (1985) 219-226
121. Irimura T., Ota D.M., and Cleary K.R. Ulex europeus agglutinin I-reactive high molecular weight glycoproteins of adenocar-cinoma of distal colon and rectum and their possible relationship with metastatic potential. Cancer Res 47 (1987) 881-889
122. Boland C.R., Montgomery C.K., and Kim Y.S. Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation. Proc Natl Acad Sci USA 79 (1982) 2051-2055
123. Boland C.R., Montgomery C.K., and Kim Y.S. A cancer-associated mucin alteration in benign colonic polyps. Gastroenterology 82 (1982) 664-672
124. Boland C.R., Lance P., Levin B., Riddell R.H., and Kim Y.S. Abnormal goblet cell glycoconjugates in rectal biopsies associated with an increased risk of neoplasia in patients with ulcerative colitis: early results of a prospective study. Gut 25 (1984) 1364-1371
125. Cooper H.S., and Reuter V.E. Peanut lectin-binding sites in polyps of the colon and rectum. Adenomas, hyperplastic polyps, and adenomas with in situ carcinoma. Lab Invest 49 (1983) 655-661
126. Irimura T., Carlson D.A., Price J., Yamori T., Giavazzi R., Ota D.M., and Cleary K.R. Differential expression of a sialoglycoprotein with an approximate molecular weight of 900,000 on metastatic human colon carcinoma cells growing in culture and in tumor tissues. Cancer Res 48 (1988) 2353-2360
127. Ishikawa M., Dennis J.W., Man S., and Kerbel R.S. Isolation and characterization of spontaneous wheat germ agglutinin-resistant human melanoma mutants displaying remarkably different metastatic profiles in nude mice. Cancer Res 48 (1988) 665-670
128. Dennis J.W. Different metastatic phenotypes in two genetic classes of wheat germ agglutinin-resistant tumor cell mutants. Cancer Res 46 (1986) 4594-4600